Unknown PHASE3 INTERVENTIONAL 2-arm NCT01429649

Study of Ablation for the Pulmonary Focal Pure Ground Glass Opacity (pGGO) (pGGO)

A Prospective Study of Ablation of Pulmonary Focal Pure Ground Glass Opacity

Sponsor: Dongfang Hospital Beijing University of Chinese Medicine

Interventions cryotherapy or radiofrequency ablation

Updated 6 times since 2017 Last updated: Sep 6, 2011 Started: Sep 30, 2011 Primary completion: Oct 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01429649, this PHASE3 trial focuses on Pulmonary Lesions and remains ongoing. Sponsored by Dongfang Hospital Beijing University of Chinese Medicine, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
May 2019 — Jan 2021 [monthly]

Unknown Status PHASE3
Jun 2018 — May 2019 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dongfang Hospital Beijing University of Chinese Medicine

Data source: Dongfang Hospital Beijing University of Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fuzhou, China